Event Details

October 01, 2018

Description

Khiron recognized first sales

Participants (1)

Name Type Mentions
Khiron Life Sciences Corp organization 8 View Entity

Source Documents (1)

HOUSE_OVERSIGHT_024872.jpg

Financial Research Report / Equity Research • 2.15 MB
View

This document is a page from a Cowen Collaborative Insights equity research report dated February 25, 2019. It analyzes several companies in the cannabis and tobacco sectors, including GTI, Khiron Life Sciences, Level Brands, Tilray, and Turning Point Brands, providing revenue figures, stock ratings, and acquisition details. The document bears a House Oversight Committee Bates stamp, suggesting it was included in document production for a congressional investigation, likely related to financial institutions, though the page itself contains no direct references to Jeffrey Epstein.

Related Events

Events with shared participants

Khiron Life Sciences entered an MOU with Dayacann.

2019-01-01 • Chile

View

Khiron acquires NettaGrowth International Inc.

2019-01-01 • Uruguay

View

Event Metadata

Type
Unknown
Location
Latin America
Significance Score
5/10
Participants
1
Source Documents
1
Extracted
2025-11-20 18:26

Additional Data

Source
HOUSE_OVERSIGHT_024872.jpg
Date String
October 2018

Discussion 0

Sign in to join the discussion

No comments yet

Be the first to share your thoughts on this epstein event